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‘World series’ to strengthen evidence-based practiceIn a worldwide context of continuously increasing pres-
sure toward more effective, safe, and efficient health care,
relating the quality of evidence from clinical research to
the quality of practice recommendations and guidelines de-
serves high priority. In fact, this is core business for all
those who are working at the interplay between research
and practice to improve health care and patient outcome.
Therefore, while publishing a series of 22 articles dealing
with one theme is exceptional, comprehensively addressing
the various challenges and opportunities in this area in suf-
ficient detail to stimulate further progress allows such an in-
vestment of intellectual effort and publication space.
Accordingly, the extensive contributions of the pioneers
of the ‘‘Grades of Recommendation, Assessment, Develop-
ment, and Evaluation’’ (GRADE) approach, in providing
guidance for rating quality of evidence and grading strength
of recommendations in health care, are highly appreciated.
After having published the first part of a series on this
theme [1] in a number of issues over the past 2 years, in this
issue of the Journal of Clinical Epidemiology four addi-
tional articles are presented, and in the near future another
nine will complete the series. As many outstanding experts
from all over the world are involved in this impressive and
voluminous work, we could refer to this as a ‘world series
to strengthen evidence-based practice.’ In a special edito-
rial, Guyatt, Oxman, and Sch€unemann provide an updated
overview of the series, introduce the four new topics, and
explain their use of terminology. In preparing the series,
support was obtained from a large number of excellent re-
viewers who significantly added to its quality.
In a Commentary on the GRADE series [8145], Thorn-
ton and co-workers describe the process of implementing
GRADE across the clinical guideline program of the British
National Institute for Health and Clinical Excellence
(NICE) since 2007. They report that GRADE has positively
been received in NICE, but some areas require further
work, such as dealing with imprecision, more than two al-
ternative interventions, and nonrandomized and diagnostic
accuracy studies. Experience with clinical guideline devel-
opment process is also reported from Estonia in a Commen-
tary by Bero et al. They show that Estonia has made
substantial progress in guideline development and imple-
mentation, in the context of a broader program aiming for
systematic quality improvement in health care. Moreover,
the Estonia experience may be useful for other low-
resource countries.0895-4356 2013 Elsevier Inc.
http://dx.doi.org/10.1016/j.jclinepi.2012.12.001
Open access under CC BY-NC-ND license. Methodological innovation in clinical epidemiological
research is addressed in a number of interesting
contributions.
Smits and colleagues raise the issue that studies of deter-
minants of recurrent disease often yield unexpected and
even paradoxical findings as to the associations observed.
Using a numerical example, they show that this phenome-
non, referred to as ‘index event bias,’ may be the result
of selection of patients on the basis of previous disease.
Pilot studies are often important in the phase of prepar-
ing the final protocol of randomized trials, and such studies
should be sufficiently informative to make appropriate de-
cisions as to possible adaptations in the study design. How-
ever, a well-crystallized methodology of determining the
required optimal sample size for pilot trials is lacking.
Therefore, the analysis and recommendations by Cocks
and Torgerson, who present a confidence interval approach
for sample size calculations for pilot randomized trials, are
welcomed as innovative and helpful.
Brenner et al studied the potential merits and pitfalls
that, in the evaluation of cancer screening programs, may
result from matching cancer-free controls to cancer cases
as to factors such as age and sex. Using an example from
colorectal cancer screening, they assessed the expected im-
pact of such matching on the observed validity and specific-
ity of fecal occult blood tests at various cut points. The
authors show that matching may indeed lead to biased esti-
mates of the specificity, and make recommendations on
how to avoid this.
As indirect comparisons are increasingly used for evalu-
ating the comparative effectiveness of various interven-
tions, assessing key assumptions that underlie the validity
of such indirect comparisons is important. Therefore,
Xiong et al applied the Trial Similarity and Evidence Con-
sistency Assessment (TSECA) framework to 94 Cochrane
systematic reviews, which was complemented by a detailed
case study providing further insight into the usefulness of
the framework. The authors conclude that overall trial sim-
ilarity and evidence consistency scores do not seem accu-
rate for predicting inconsistency between direct and
indirect estimates, and that the proposed assessment frame-
work can be useful for identifying relevant between-trial
differences.
The observed prevalence of multimorbidity may depend
on the studied databases and study populations. In a study
of chronic disease and disease combinations in the elderly
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eases included, and case definition, Van den Bussche and
his team found statistically different prevalences. The dif-
ferences were small for individual conditions, but increased
with the number of conditions under study. Therefore, in-
vestigators should be cautious when making conclusions
on prevalence or multimorbidity based on a single database.
While it is a well-known phenomenon that nonresponse
to patient-reported outcome (PRO) questionnaires may bias
study results, Hutchings and co-workers estimated the im-
pact of non-response by comparing the outcomes of early
and late responders. Based on a large study of the outcome
of surgical procedures, they conclude that non-response to
PRO questionnaires introduces slight bias, that nonre-
sponders may have worse outcomes, and that differences
between hospitals must be taken into account for making
appropriate comparisons. Morris et al evaluated the reduc-
tion of non-response in questionnaire completion in an in-
fertility survey among women using a randomized trial
design comparing various modes of completion: online, pa-
per mail, telephone, and making a choice of these three
modes. It was found that mail yielded the best response,
although differences were small. Online surveys seem an
acceptable alternative. The response may be increased by
offering participants a choice of response modes.Connecting to an earlier article by Adair and Rao [2],
the groups of Nojilana and Rao, respectively, discuss the
opportunities and challenges of reliably measuring and
comparing diabetes-related mortality, the need for interna-
tional guidelines, and the requirements for such guidelines.
Earlier in this editorial the phrase ‘investigators should
be cautious when making conclusions’ was used. Gaylor
undertook a literature search on (variants of) the phrase
‘these results, however, should be interpreted with caution.’
For various reasons, highlighted in a letter, Gaylor proposes
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